title: [Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?].
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital de Sabadell, Corporació Sanitària i Universitària Parc Taulí, Universidad Autónoma de Barcelona, Sabadell, Barcelona, España.
authors.forename: Lara
authors.initials: L
authors.lastname: Albert Fàbregas
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital de Sabadell, Corporació Sanitària i Universitària Parc Taulí, Universidad Autónoma de Barcelona, Sabadell, Barcelona, España. Electronic address: josmi.gonza@gmail.com.
authors.forename: José Miguel
authors.initials: JM
authors.lastname: González-Clemente
mesh_terms: D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D019468:Disease Management; D057915:Drug Substitution / Q000191:economics; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000517:prevention & control; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011322:Primary Prevention; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013030:Spain / Q000453:epidemiology
chemical_list: D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors